SCHEMBL4086283

SCHEMBL4086283

O=C(O)c1ccc(C(=O)Nc2cccc(Nc3nc(-c4cccnc4)cs3)c2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.74
RAB9A P51151 5/20 0.74
MEN1 O00255 7/20 0.69
KMT2A Q03164 7/20 0.69
MAPT P10636 5/20 0.67
GAA P10253 2/20 0.67
NPSR1 Q6W5P4 1/20 0.67
ALDH1A1 P00352 2/20 0.62
PKM P14618 1/20 0.62
ABL1 P00519 3/20 0.62
PDGFRB P09619 2/20 0.62
HDAC3 O15379 1/20 0.62
KDR P35968 1/20 0.62
HDAC4 P56524 1/20 0.62
HDAC1 Q13547 1/20 0.62
HDAC7 Q8WUI4 1/20 0.62
HDAC2 Q92769 1/20 0.62
HDAC10 Q969S8 1/20 0.62
HDAC11 Q96DB2 1/20 0.62
HDAC8 Q9BY41 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4090805 0.93 ABL1 (0.71) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL4077558 0.89 NPC1 (0.68) NPC1RAB9AMEN1KMT2AMAPT
Water SCHEMBL3810741 0.89 NPC1 (0.63) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL23539303 0.87 MEN1 (0.81) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL8470941 0.87 HDAC1 (0.73) NPC1RAB9AMEN1KMT2AMAPT
Water SCHEMBL3810749 0.86 NPC1 (0.60) NPC1RAB9AMEN1KMT2AMAPT
Water SCHEMBL4092234 0.86 HDAC1 (0.72) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL14155921 0.86 RAB9A (1.00) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL3794413 0.85 ABL1 (0.76) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL4087570 0.85 ABL1 (0.78) NPC1RAB9AMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065734-A1 NOVEL BIFUNCTIONAL COMPOUNDS WHICH INHIBIT PROTEIN KINASES AND HISTONE DEACETYLASES 4SC AG (DE) 2011-03-17 US disclosed
EP-2060565-A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases 4SC AG (DE) 2009-05-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065734-A1 NOVEL BIFUNCTIONAL COMPOUNDS WHICH INHIBIT PROTEIN KINASES AND HISTONE DEACETYLASES HDAC1, HDAC11, MAP2K2 NPC1 3094/4885RAB9A 2184/4885MEN1 2479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.